ABCA1 and Tangier disease: Mutations that inactivate ABCA1 lead to Tangier disease, a disorder characterized by increase extrahepatic tissue cholesterol accumulation, near-absence of plasma HDL, decrease plasma LDL concentrations, and increase plasma TG levels [23].